AnteoTech Limited

ADO

AU000000ADO8

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 12:10:22 2024-12-03 am EST			5-day change	1st Jan Change
0.0190 ^AUD	0.00%		-5.00%	-47.22%

Nov. 21	AnteoTech Opens AU$5 Million Entitlement Offer; Shares Up 5%	MT
Oct. 29	AnteoTech Secures AU$4 Million Grant to Boost Battery Anode Development; Shares Jump 8%	MT

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about AnteoTech Limited

AnteoTech Opens AU$5 Million Entitlement Offer; Shares Up 5%	Nov. 20	MT
AnteoTech Secures AU$4 Million Grant to Boost Battery Anode Development; Shares Jump 8%	Oct. 28	MT
AnteoTech Secures First Purchase Order for Battery Anode Technology; Shares Up 20%	Oct. 14	MT
AnteoTech Limited Reports Earnings Results for the Full Year Ended June 30, 2024	Aug. 27	CI
AnteoTech Limited Auditor Raises 'Going Concern' Doubt	Aug. 26	CI
AnteoTech Begins Commercial Evaluation of AnteoBind NXT with India's Vidcare Innovations	Aug. 14	MT
AnteoTech Signs Five-Year Purchase Agreement for AnteoBind product; Shares Down Nearly 5%	Jul. 30	MT
AnteoTech Completes AU$1.4 Million Share Purchase Plan	May. 14	MT
AnteoTech Extends Closing Date of Share Purchase Plan	May. 01	MT
Anteotech Seeks to Raise AU$6 Million From Share Placement; Shares Fall 26%	Apr. 08	MT
AnteoTech Receives AU$1.39 Million from Queensland Critical Minerals and Battery Technology Fund; Shares Down 3%	Mar. 26	MT
AnteoTech Settles Patent Claims for AU$300,000	Mar. 04	MT
AnteoTech Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 27	CI
Anteotech Completes Construction of Anteo X Production Facility in Brisbane; Shares Climb 6%	Feb. 14	MT
AnteoTech Produces Anode Material Containing Proprietary Technology	Dec. 07	MT
AnteoTech Receives AU$3.8 Million R&D Tax Rebate; Shares Rise 3%	23-10-12	MT
AnteoTech Limited(ASX:ADO) dropped from S&P Global BMI Index	23-09-18	CI
AnteoTech Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-29	CI
AnteoTech Limited Announces Appointment of Mr. Andrew Cook as Company Secretary, Effective from 28 August 2023	23-08-22	CI
Anteotech Limited Announces Appointment of Mr. Andrew Cook as Chief Financial Officer	23-08-22	CI
AnteoTech Halts Trade	23-07-24	MT
AnteoTech Limited Announces Retirement of Christopher Parker from the Board of Directors	23-06-27	CI
Anteotech to Undergo Major Rebranding; Shares Jump 10%	23-05-22	MT
Anteotech Limited Announces Changes to Leadership Team	23-04-30	CI
Anteotech Limited Announces Changes to Leadership Team	23-04-30	CI

AnteoTech Limited is an Australia-based company engaged in providing solutions for the clean energy and life sciences markets using applied materials technology. The principal activities of the Company consist of development and commercialization of nanotechnologies with surface management applications. The Companyâs lead product, Anteo X, provides significant improvement in anode performance and the Company partners with global suppliers in lithium-ion battery manufacturing. Its clean energy technology (CET) technologies improve the energy densities, cycle life and cost- effectiveness of lithium-ion batteries. The Company has two programs underway: Anteo X, its binder additive and the High Silicon Anode technology. The Life Sciences division services the point-of-care and in vitro diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.

Employees

Sector

Biotechnology & Medical Research

Calendar

2025-02-25 - Q2 2025 Earnings Release (Projected)

More about the company